High levels of pipeline activity are being observed in Narcolepsy treatment during 2019. Clinical development activities are being undertaken by more than 20 companies including Avadel Pharmaceuticals Plc, Axsome Therapeutics Inc, Balance Therapeutics Inc, Bioprojet SCR, Evotec AG and others.
A Significant contribution to the Narcolepsy pipeline is being observed from emerging companies opting for new approaches to clinical development strategy. The early stage and late-stage Narcolepsy pipeline included 20 compounds, driven by increasing number of targeted therapies. Progress is being made in accelerating compounds into advanced stages. However, fluctuating trends are being observed in average duration across three phases.
Increased understanding of underlying causes of Narcolepsy condition and increased access to investments is encouraging growth of Narcolepsy drug pipeline. However, despite high levels of pipeline activity, increasing clinical trial costs and decreasing drug approval rates is requiring companies to focus more on understanding clinical development pipeline compounds.
The research study is structured to provide clear and actionable insights into Narcolepsy drug pipeline for companies to optimize spending levels by understanding competition, their pipeline products and prospect of further advances over the next few years.
The report addresses the discovery, research and pre-clinical stage active Narcolepsy therapeutic candidates. Further, drugs in clinical stage including phase 1, phase 2, phase 3 and pre-registration phases are also analyzed.
The current report examines the current Narcolepsy pipeline along with current development status, regulatory progress, mechanism of action, route of administration, collaborating companies, sponsors, molecule type, and research/discovery details.
In addition to drug overview, recent developments, the report also provides mechanism of action, Pre-clinical trial details and Clinical trial details for each of the drug candidates of Narcolepsy. Further, orphan drug status, fast track designation, grants awarded and other special status for Narcolepsy pipeline compounds are also included.
This study was produced independently by VPAResearch from our proprietary databases, primarily to assist users to develop in-depth understanding of 2019 Narcolepsy pipeline and formulate effective research and development strategies.
Our integrated data reports are built through robust research methodology to ensure our users can build on the insights and data accuracy for their expansion plans. Both primary and secondary research methods are used with stringent quality checks at each stage to evaluate trends, analysis and forecasts.
Scope of the Research
Narcolepsy Pipeline candidates- - Pre-clinical Phase: Discovery, research, pre-clinical
- Early Phase: Phase 1 and Phase 2 Narcolepsy drugs
- Late phase: Phase 3 and in-approval Narcolepsy drugs
Companies involved in the Pipeline- - Company overview
- Narcolepsy therapeutic treatment activities
Details for each Narcolepsy drug candidate- - Snapshot
- Drug Name
- Alternative Names
- Molecule Type
- Orphan Drug Status
- Drug Overview
- Mechanism of Action
- Current Status
- Trial Details
Other details - Pre-clinical trials for each drug candidate
- Clinical trials for each drug candidate
Recent Narcolepsy therapeutic candidates, clinical trials, investments, grants, partnerships, licenses, awards and other news
Our reports have been used by over 10K customers, including:
Biopreservation refers to the process of preserving cells, tissues or organs outside of their native environment for extended period of time. It has emerged as an effective preservation technique for long-term storage. Owing to this, biopreservation has become vital for the success of various clinical and commercial...
Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, Clinical), By Service (Clinical Monitoring, Regulatory/Medical Affairs), And Segment Forecasts, 2021 - 2028 Healthcare CRO Market Growth & Trends The global healthcare...
Drug Discovery Market Report Overview Drug Discovery market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Drug Discovery market types and applications. It is a focused study on Drug Discovery market space including global and regional eight-year...
120 pages •
By Infiniti Research Limited
• Dec 2020
Global Microarray Biochips Market 2020-2024
The analyst has been monitoring the microarray biochips market and it is poised to grow by $ 10.22 bn during 2020-2024 progressing at a CAGR of 20% during the forecast period. Our report on microarray biochips market provides a holistic analysis, market size and forecast, trends,...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the biosimilar therapeutic peptides market are Eli Lilly, Sanofi, Takeda Pharmaceuticals, Teva Pharmaceuticals, Pfizer Inc., Amgen Inc., AstraZeneca PLC, GlaxoSmithKline (GSK), Novartis AG and Novo Nordisk A/S. The global biosimilar therapeutic peptides market is expected to decline from $0.80 billion in 2019 to $0.77...
120 pages •
By Infiniti Research Limited
• Dec 2020
Global Gel Electrophoresis Market 2020-2024
The analyst has been monitoring the gel electrophoresis market and it is poised to grow by $ 381.92 mn during 2020-2024 progressing at a CAGR of 5% during the forecast period. Our report on gel electrophoresis market provides a holistic analysis, market size and forecast, trends,...
The comprehensive 2,400 page research study on COVID-19 therapeutic and vaccine pipeline candidates, completed, ongoing and planned clinical trials across phases, countries, companies and institutes/hospitals. The global COVID-19 market size outlook remains robust driven by huge potential for administration to 2 billion populations,...
This report analyzes the regulatory framework for the clinical trials of orphan drugs in rare and orphan diseases.The report also analyzes the trends and characteristics of clinical trials conducted on rare diseases from 1999-2018, using information from various sources.
This report covers an overview...
Pharmacovigilance Market Size, Share & Trends Analysis Report By Service Provider (In-house, Contract Outsourcing), By Product Life Cycle, By Type, By Process Flow, By Therapeutic Area, By End Use, And Segment Forecasts, 2021 - 2028
Pharmacovigilance Market Growth & Trends
The global pharmacovigilance...